- Home
- ATLX vs IKNA Comparison
ATLX vs IKNA Comparison
Compare ATLX & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLX
- IKNA
- Stock Information
- Founded
- ATLX 2011
- IKNA 2016
- Country
- ATLX Brazil
- IKNA United States
- Employees
- ATLX N/A
- IKNA N/A
- Industry
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- ATLX Industrials
- IKNA Health Care
- Exchange
- ATLX Nasdaq
- IKNA Nasdaq
- Market Cap
- ATLX 101.9M
- IKNA 81.6M
- IPO Year
- ATLX N/A
- IKNA 2021
- Fundamental
- Price
- ATLX $6.90
- IKNA $1.50
- Analyst Decision
- ATLX Strong Buy
- IKNA Buy
- Analyst Count
- ATLX 3
- IKNA 2
- Target Price
- ATLX $33.17
- IKNA $3.00
- AVG Volume (30 Days)
- ATLX 85.6K
- IKNA 445.7K
- Earning Date
- ATLX 11-08-2024
- IKNA 03-11-2025
- Dividend Yield
- ATLX N/A
- IKNA N/A
- EPS Growth
- ATLX N/A
- IKNA N/A
- EPS
- ATLX N/A
- IKNA N/A
- Revenue
- ATLX $543,657.00
- IKNA $659,000.00
- Revenue This Year
- ATLX N/A
- IKNA N/A
- Revenue Next Year
- ATLX $8,777.97
- IKNA N/A
- P/E Ratio
- ATLX N/A
- IKNA N/A
- Revenue Growth
- ATLX N/A
- IKNA N/A
- 52 Week Low
- ATLX $6.12
- IKNA $1.22
- 52 Week High
- ATLX $26.24
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- ATLX 48.46
- IKNA 38.66
- Support Level
- ATLX $6.80
- IKNA $1.50
- Resistance Level
- ATLX $7.25
- IKNA $1.56
- Average True Range (ATR)
- ATLX 0.45
- IKNA 0.08
- MACD
- ATLX 0.05
- IKNA -0.01
- Stochastic Oscillator
- ATLX 37.23
- IKNA 20.00
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. They intend to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.